| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Molecular and Medical Pharmacology, Division of Nuclear Medicine, UCLA School of Medicine
Laboratory of Structural Biology and Molecular Medicine, University of California, Los Angeles, California
Correspondence: For correspondence or reprints contact: Johannes Czernin, MD, Department of Molecular and Medical Pharmacology, B2-085 J CHS, 10833 Le Conte Avenue University of California, Los Angeles. CA 90024-6948.
ABSTRACT
PET with 13N-ammonia permits the noninvasive quantification of myocardial blood flow (MBF) in humans. The present study was done to assess the reproducibility of quantitative blood flow measurements at rest and during pharmacologically induced hyperemia in healthy individuals. Methods: Thirty healthy volunteers (26 men, 4 women) were studied. Paired measurements of MBF at rest (n = 21), during adenosine (n = 15) and during dipyridamole (n = 7) were performed using a two-compartment model for 13N-ammonia PET. The mean difference between baseline and follow-up blood flow (% difference) was calculated to assess reproducibility. Results: No significant difference was observed between resting blood flow at baseline or follow-up (15.8% ± 15.8%; p = ns). Baseline and follow-up resting blood flow were linearly correlated (r = 0.63, p < 0.005). Normalization of resting blood flow to the rate pressure product improved the reproducibility significantly (15.8% ± 15.8% versus 10.1% ± 10.5%, p < 0.05). Baseline and follow-up hyperemic myocardial blood flow did not differ (11.8% ± 9.4%; p = ns) and were linearly correlated (r = 0.69, p < 0.0005). Conclusion: MBF at rest can be measured reproducibly with 13N-ammonia PET. The individual response to pharmacologic stress appears to be relatively consistent. Thus, serial blood flow measurements with 13N-ammonia PET can be used to quantify the effect of various interventions on MBF and vasodilatory reserve.
Key Words: myocardial blood flow • pharmacologic stress • PET
This article has been cited by other articles:
|
|
 |
|
  P. T. Siegrist, O. Gaemperli, P. Koepfli, T. Schepis, M. Namdar, I. Valenta, F. Aiello, S. Fleischmann, H. Alkadhi, and P. A. Kaufmann Repeatability of Cold Pressor Test-Induced Flow Increase Assessed with H215O and PET J. Nucl. Med., September 1, 2006; 47(9): 1420 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Chareonthaitawee, S. D. Christenson, J. L. Anderson, B. J. Kemp, D. O. Hodge, E. L. Ritman, and R. J. Gibbons Reproducibility of Measurements of Regional Myocardial Blood Flow in a Model of Coronary Artery Disease: Comparison of H215O and 13NH3 PET Techniques J. Nucl. Med., July 1, 2006; 47(7): 1193 - 1201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Brunken, J. K. Perloff, J. Czernin, R. Campisi, S. Purcell, P. D. Miner, J. S. Child, and H. R. Schelbert Myocardial perfusion reserve in adults with cyanotic congenital heart disease Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1798 - H1806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Jagathesan, P. A. Kaufmann, S. D. Rosen, O. E. Rimoldi, F. Turkeimer, R. Foale, and P. G. Camici Assessment of the Long-Term Reproducibility of Baseline and Dobutamine-Induced Myocardial Blood Flow in Patients with Stable Coronary Artery Disease J. Nucl. Med., February 1, 2005; 46(2): 212 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Kaufmann and P. G. Camici Myocardial Blood Flow Measurement by PET: Technical Aspects and Clinical Applications J. Nucl. Med., January 1, 2005; 46(1): 75 - 88. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Duvernoy, J. Martin, K. Briesmiester, A. Bargardi, O. Muzik, and L. Mosca Myocardial Blood Flow and Flow Reserve in Response to Hormone Therapy in Postmenopausal Women with Risk Factors for Coronary Disease J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2783 - 2788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Koepfli, T. F. Hany, C. A. Wyss, M. Namdar, C. Burger, A. V. Konstantinidis, T. Berthold, G. K. von Schulthess, and P. A. Kaufmann CT Attenuation Correction for Myocardial Perfusion Quantification Using a PET/CT Hybrid Scanner J. Nucl. Med., April 1, 2004; 45(4): 537 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Schindler, E. U. Nitzsche, M. Olschewski, I. Brink, M. Mix, J. Prior, A. Facta, M. Inubushi, H. Just, and H. R. Schelbert PET-Measured Responses of MBF to Cold Pressor Testing Correlate with Indices of Coronary Vasomotion on Quantitative Coronary Angiography J. Nucl. Med., March 1, 2004; 45(3): 419 - 428. [Abstract] [Full Text]
|
|
|
|
|
|
C. A. Wyss, P. Koepfli, K. Mikolajczyk, C. Burger, G. K. von Schulthess, and P. A. Kaufmann Bicycle Exercise Stress in PET for Assessment of Coronary Flow Reserve: Repeatability and Comparison with Adenosine Stress J. Nucl. Med., February 1, 2003; 44(2): 146 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G Camici and O. E Rimoldi Myocardial blood flow in patients with hibernating myocardium Cardiovasc Res, February 1, 2003; 57(2): 302 - 311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Paiva, J. Laakso, H. Laine, R. Laaksonen, J. Knuuti, and O. T. Raitakari Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1241 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tawakol, M. A. Forgione, M. Stuehlinger, N. M. Alpert, J. P. Cooke, J. Loscalzo, A. J. Fischman, M. A. Creager, and H. Gewirtz Homocysteine impairs coronary microvascular dilator function in humans J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1051 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. H. Buus, M. Bottcher, F. Hermansen, M. Sander, T. T. Nielsen, and M. J. Mulvany Influence of Nitric Oxide Synthase and Adrenergic Inhibition on Adenosine-Induced Myocardial Hyperemia Circulation, November 6, 2001; 104(19): 2305 - 2310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Otsuka, H. Watanabe, K. Hirata, K. Tokai, T. Muro, M. Yoshiyama, K. Takeuchi, and J. Yoshikawa Acute Effects of Passive Smoking on the Coronary Circulation in Healthy Young Adults JAMA, July 25, 2001; 286(4): 436 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bottcher, M. M. Madsen, J. Refsgaard, N. H. Buus, I. Dorup, T. T. Nielsen, and K. Sorensen Peripheral Flow Response to Transient Arterial Forearm Occlusion Does Not Reflect Myocardial Perfusion Reserve Circulation, February 27, 2001; 103(8): 1109 - 1114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Kaufmann, T. Gnecchi-Ruscone, M. di Terlizzi, K. P. Schafers, T. F. Luscher, and P. G. Camici Coronary Heart Disease in Smokers : Vitamin C Restores Coronary Microcirculatory Function Circulation, September 12, 2000; 102(11): 1233 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Schwitter, T. DeMarco, S. Kneifel, G. K. von Schulthess, M. C. Jorg, H. Arheden, S. Ruhm, K. Stumpe, A. Buck, W. W. Parmley, et al. Magnetic Resonance-Based Assessment of Global Coronary Flow and Flow Reserve and Its Relation to Left Ventricular Functional Parameters : A Comparison With Positron Emission Tomography Circulation, June 13, 2000; 101(23): 2696 - 2702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Campisi, J. Czernin, H. Schoder, J. W. Sayre, and H. R. Schelbert L-Arginine Normalizes Coronary Vasomotion in Long-Term Smokers Circulation, February 2, 1999; 99(4): 491 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Duvernoy, C. Meyer, V. Seifert-Klauss, F. Dayanikli, I. Matsunari, J. Rattenhuber, C. Hoss, H. Graeff, and M. Schwaiger Gender differences in myocardial blood flow dynamics: Lipid profile and hemodynamic effects J. Am. Coll. Cardiol., February 1, 1999; 33(2): 463 - 470. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
